Amylgen

Exhibitor

Amylgen is a preclinical CRO with relevant disease models Alzheimer’s disease and other CNS pathologies (schizophrenia, major depression, anxiety). We offer robust drug efficacy data and high value interpretation to assist drug discovery companies in evaluating the potential of their therapeutic compounds. Over the last 9 years, we successfully determined compound efficacy and side effects in numerous projects for academia, biotech, pharma and food industry clients.



website

 

 

DOWNLOAD PROSPECTUS

 

 

For speaking, sponsorship and exhibition opportunities contact jonathan.mottram@terrapinn.com
Tel: +65 6322 2738